Silo Pharma, Inc. (SILO) Operating income 2017–2025
Silo Pharma, Inc. (SILO) annual operating income history from SEC filings — each fiscal year as reported.
-$4.3MFY2025 · since FY2017: -$490,871 → -$4.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.3M | +9.0% |
| FY2024 | -$4.7M | -22.0% |
| FY2023 | -$3.9M | -6.3% |
| FY2022 | -$3.6M | -32.2% |
| FY2021 | -$2.7M | -24.6% |
| FY2020 | -$2.2M | -136.6% |
| FY2019 | -$930,403 | -56.6% |
| FY2018 | -$594,242 | -21.1% |
| FY2017 | -$490,871 | — |
Source: SEC XBRL filings · For reference only · Not investment advice